Stock data
TransMedics Group, Inc. (TMDX)
TransMedics Group, Inc. (TMDX) reported revenue of US$605.49M and net income of US$190.29M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$605.49M | US$362.81M | US$108.58M | US$190.29M | — |
| 2024 | US$441.54M | US$262.08M | US$37.50M | US$35.46M | — |
| 2023 | US$241.62M | US$154.09M | -US$28.73M | -US$25.03M | — |
| 2022 | US$93.46M | US$65.27M | -US$31.44M | -US$36.23M | — |
| 2021 | US$31.39M | US$21.16M | -US$39.43M | -US$44.22M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$189.95M | US$14.68M | — |
| 2026-03-31 | US$173.93M | US$7.32M | — |
| 2025-12-31 | US$160.76M | US$105.38M | — |
| 2025-09-30 | US$143.82M | US$24.32M | — |
| 2025-06-30 | US$157.37M | US$34.91M | — |
| 2025-03-31 | US$143.54M | US$25.68M | — |
| 2024-12-31 | US$121.62M | US$6.86M | — |
| 2024-09-30 | US$108.76M | US$4.22M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.